| | | | | | | | | | |
| |
|
|
| Dockets Entered
On February 9, 2007
|
|
|
|
|
|
|
| |
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
| |
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
| |
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
| |
|
|
| 2006P-0498
|
| Use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods
|
| |
|
|
| 2007P-0052
|
| determine whether a listed drug(Brethine) that has been voluntarily shortened from distribution and sale was shortened for reasons other than for safety or effectiveness reasons
|
|
| |
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
| |
|
|
| C 251
|
| Consumer Healthcare Products Association (CHPA)
|
| Vol #:
|
| 86
|
|
| |
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
| |
|
|
| LET 18460
|
| The Origin Foods SDN BHD
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18461
|
| Taian Zhongxin Lingzhi Technology and Development Co. Ltd.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18462
|
| Taian Zhongxin Lingzhi Technology and Development Co. Ltd.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18463
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18464
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18465
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18466
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18467
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18468
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18469
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18470
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18471
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18472
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18473
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18474
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18475
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18476
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18477
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18478
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18479
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18480
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| LET 18481
|
| Enzymatic Therapy, Inc.
|
| Vol #:
|
| 168
|
| |
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
| |
|
|
| C 54
|
| M Marmolejo
|
| Vol #:
|
| 6
|
| |
|
|
| C 55
|
| J Embry
|
| Vol #:
|
| 6
|
|
| |
|
| 2006P-0498
|
| Use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods
|
|
| | | | | | | | |
|
| |
|
| C 1
|
| O Deutsch
|
| Vol #:
|
| 1
|
| |
|
|
| C 2
|
| C Dietericks
|
| Vol #:
|
| 1
|
| |
|
|
| C 3
|
| L Cheng
|
| Vol #:
|
| 1
|
| |
|
|
| C 4
|
| Mrs Williams
|
| Vol #:
|
| 1
|
| |
|
|
| C 5
|
| S DeRuyter
|
| Vol #:
|
| 1
|
| |
|
|
| C 6
|
| B Smith
|
| Vol #:
|
| 1
|
| |
|
|
| C 7
|
| E Maimone
|
| Vol #:
|
| 1
|
| |
|
|
| C 8
|
| W Sutliff
|
| Vol #:
|
| 1
|
| |
|
|
| C 9
|
| M Barajikian
|
| Vol #:
|
| 1
|
| |
|
|
| C 10
|
| R Benchoff
|
| Vol #:
|
| 1
|
| |
|
|
| C 11
|
| D Lind
|
| Vol #:
|
| 1
|
| |
|
|
| C 12
|
| M Frohman
|
| Vol #:
|
| 1
|
| |
|
|
| C 13
|
| M Moser
|
| Vol #:
|
| 1
|
| |
|
|
| C 14
|
| Form Letter count 282
|
| Vol #:
|
| 2
|
| |
|
|
| 2007P-0052
|
| determine whether a listed drug(Brethine) that has been voluntarily shortened from distribution and sale was shortened for reasons other than for safety or effectiveness reasons
|
| |
|
|
| CP 1
|
| West-Ward Pharmaceutical Corp.
|
| Vol #:
|
| 1
|
|
|
